Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2021-09-20

FDA Approved: DESVENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA action on Sun Pharmaceutical's supplemental application for desvenlafaxine, likely updating labeling or expanding indications. The submission concerns the d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desvenlafaxine (Desvenlafaxine)

Snippet

SUPPL AP for DESVENLAFAXINE (DESVENLAFAXINE)